ArticleNaunyn-Schmiedeberg's archives of pharmacology2025

Tubeimoside I inhibits the growth of triple-negative breast cancer via the NR3 C2/PI3 K/AKT signaling pathway.

Qinxiang Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.